Embolization Proves Its Mettle for Subdural Hematoma
PHOENIX — For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic system and one with the Squid liquid embolic system were reported with what one presenter called “very consistent” findings at the closing late-breaking science session of the […]
Erectile Dysfunction Drugs Plus Nitrates Still a Losing Combination, Study Shows
As expected, men taking nitrates for stable coronary artery disease (CAD) fared poorly if they added certain erectile dysfunction (ED) drugs to their medicine cabinet, a Swedish population-based study found. Compared with nitrate users not on phosphodiesterase-5 (PDE5) inhibitor treatment for ED, those who had both types of drugs in their medication history tended to […]
Paclitaxel Devices Safe in PAD In Medicare Data Beyond 3 Years
ATLANTA — Paclitaxel-coated devices for femoropopliteal artery revascularization were not associated with any excess mortality risk in the latest update from Medicare data. The risk of death from any cause, if anything, trended slightly lower (hazard ratio 0.98, 95% CI 0.96-0.99) with paclitaxel-eluting stents or -coated balloons compared with bare metal stent or percutaneous transluminal […]
Home Walking Program Eases Peripheral Artery Disease Limitations
Motivating patients with peripheral artery disease (PAD) and intermittent claudication to start walking at home improved their exercise capacity, the MOSAIC trial showed. Six-minute walk distance improved by 16.7 m more with the physical therapist-led intervention compared with usual care alone at 3 months (from 352.9 m at baseline to 380.6 m vs 369.8 to […]